We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Tootsie Roll Industries
TR
$2.63B
| $566K | ﹤0.01% |
14,311
+3,254
| +29% | +$132K |
2025 Q3
3 quarters
|
|
3102
Lifezone Metals
LZM
$304M
| $564K | ﹤0.01% |
145,484
+4,590
| +3% | +$21.4K |
2024 Q3
7 quarters
|
|
3103
Columbia Research Enhanced Core ETF
RECS
$6.16B
| $563K | ﹤0.01% |
13,006
+1,753
| +16% | +$74.3K |
2026 Q1
1 quarter
|
|
3104
MainStreet Bancshares
MNSB
$173M
| $563K | ﹤0.01% |
22,793
+523
| +2% | +$12.3K |
2019 Q2
28 quarters
|
|
3105
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.78B
| $563K | ﹤0.01% |
22,338
+800
| +4% | +$20.2K |
2026 Q1
1 quarter
|
|
3106
MGP Ingredients
MGPI
$336M
| $560K | ﹤0.01% |
31,966
-7,947
| -20% | -$145K |
2018 Q3
31 quarters
|
|
3107
Coty
COTY
$2.83B
| $560K | ﹤0.01% |
259,104
-220,151
| -46% | -$475K |
2020 Q3
23 quarters
|
|
3108
JPMorgan International Research Enhanced Equity ETF
JIRE
$10.9B
| $559K | ﹤0.01% |
6,781
+1,198
| +21% | +$96.1K |
2025 Q3
3 quarters
|
|
3109
ARK Next Generation Technology ETF
ARKW
$1.85B
| $559K | ﹤0.01% |
3,859
+112
| +3% | +$15.7K |
2024 Q4
6 quarters
|
|
3110
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$753M
| $559K | ﹤0.01% |
+9,936
| New | +$530K |
2026 Q2
0 quarters
|
|
3111
The Honest Company
HNST
$513M
| $559K | ﹤0.01% |
152,617
+53,218
| +54% | +$179K |
2024 Q3
7 quarters
|
|
3112
NextDecade
NEXT
$1.68B
| $559K | ﹤0.01% |
74,077
+30,152
| +69% | +$238K |
2024 Q4
6 quarters
|
|
3113
Herbalife
HLF
$1.4B
| $558K | ﹤0.01% |
42,428
-7,018
| -14% | -$96.7K |
2024 Q4
6 quarters
|
|
3114
Liberty Global Class A
LBTYA
$2.68B
| $555K | ﹤0.01% |
48,855
+7,764
| +19% | +$92.8K |
2025 Q3
3 quarters
|
|
3115
iShares MSCI Taiwan ETF
EWT
$11.4B
| $553K | ﹤0.01% |
5,091
+300
| +6% | +$28.1K |
2020 Q4
22 quarters
|
|
3116
Evolution Metals & Technologies Corp
EMAT
$884M
| $552K | ﹤0.01% |
+83,500
| New | +$663K |
2026 Q2
0 quarters
|
|
3117
iShares US Tech Independence Focused ETF
IETC
$666M
| $551K | ﹤0.01% |
5,133
+19
| +0.4% | +$1.98K |
2020 Q3
23 quarters
|
|
3118
Innovator US Equity Ultra Buffer ETF February
UFEB
$169M
| $551K | ﹤0.01% |
14,251
-10,406
| -42% | -$396K |
2026 Q1
1 quarter
|
|
3119
AGNT Inc
AGNT
$690M
| $551K | ﹤0.01% |
101,801
+17,865
| +21% | +$98.5K |
2025 Q3
3 quarters
|
|
3120
Monte Rosa Therapeutics
GLUE
$911M
| $550K | ﹤0.01% |
22,726
-1,139
| -5% | -$21.5K |
2025 Q4
2 quarters
|
|
3121
iRadimed
IRMD
$1.09B
| $549K | ﹤0.01% |
5,746
-1,320
| -19% | -$120K |
2025 Q3
3 quarters
|
|
3122
Tempus AI
TEM
$12.3B
| $549K | ﹤0.01% |
9,478
-884
| -9% | -$44.3K |
2025 Q1
5 quarters
|
|
3123
Global X S&P 500 Covered Call ETF
XYLD
$3.36B
| $546K | ﹤0.01% |
13,390
+5,290
| +65% | +$213K |
2025 Q4
2 quarters
|
|
3124
Target Hospitality
TH
$1.36B
| $545K | ﹤0.01% |
26,774
+14,995
| +127% | +$251K |
2026 Q1
1 quarter
|
|
3125
State Street SPDR S&P International Dividend ETF
DWX
$524M
| $544K | ﹤0.01% |
11,830
+1,896
| +19% | +$88.2K |
2025 Q3
3 quarters
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.